In addition to upregulation of VEGF and HIF secondary to inactivation of the VHL gene, activation of the mammalian target of rapamycin (mTOR) pathway also leads to increased expression of HIF-1 and was implicated as a valid target in renal cell carcinoma [82,83]. This evidence concerns the gene MTOR and hereditary clear cell renal cell carcinoma.